Today's Top Health News Story

Obamacare repeal on the ropes as pivotal Republican rebuffs Trump

WASHINGTON (Reuters) - U.S. Senator Susan Collins rebuffed intense lobbying from fellow Republicans and the promise of money for her state in deciding on Monday to oppose - and likely doom - her party's last-ditch effort to repeal Obamacare. Learn More

 

More Top Health Stories

Axovant's Alzheimer's drug fails in late-stage trial, shares plummet

(Reuters) - Axovant Sciences Ltd's drug failed to improve cognitive abilities and daily activities in Alzheimer's patients, in the latest setback to finding a treatment for the memory-robbing disease that affects millions in the United States. More »

 

Vets in Philippines turn to technology to track and tackle rabies

MANILA (Reuters) - Armed with smartphones and syringes, veterinarians in the Philippines are turning to technology to fight rabies, using tracking tools to identify problem areas in mass campaigns to vaccinate dogs. More »

 

F1 team uses racing car technology to keep newborns safe in ambulances

GROVE, England (Reuters) - A Formula One racing team is employing technology that helps racing drivers survive high speed crashes to create a new device that keeps newborn babies safe during emergency transportation. More »

 

U.S. FDA joins Interpol crackdown on illicit online pharmacies

(Reuters) - Authorities from a record 123 countries, including the U.S. Food and Drug Administration, have taken action against hundreds of businesses suspected of illegally selling medicines over the internet, officials said on Monday. More »

 

FDA pours cold water on PTC Therapeutics' Duchenne drug application

(Reuters) - PTC Therapeutics Inc has not supplied persuasive evidence that its experimental drug to treat a form of Duchenne muscular dystrophy is effective, a preliminary review by scientists at the U.S. Food and Drug Administration concluded. More »

 

CVC, others explore sale of drugmaker Alvogen: Bloomberg

(Reuters) - CVC Capital Partners [CVC.UL] and other private equity owners are exploring options for generic drugmaker Alvogen, including a sale, which could be valued at about $4 billion, Bloomberg reported on Tuesday. More »

 

Venezuela doctors in protest urge stronger WHO stance on health crisis

CARACAS (Reuters) - Venezuela's doctors, fed up with what they called the World Health Organization's passive attitude toward the country's deep medical crisis, protested at the agency's Caracas office on Monday to demand more pressure on the government and additional assistance. More »

 

US immigration restrictions may slow medical research

(Reuters Health) - Recently proposed changes to U.S. immigration policy may slow the progress of medical research, some doctors argue. More »

 

EU drugs watchdog warns of staff exodus if move from London botched

FRANKFURT (Reuters) - Europe's drugs regulator could lose more than 70 percent of its staff, making it unable to function, if politicians pick the wrong new home for the London-based agency, it warned on Tuesday. More »

 

News, Photo and Web Search